Status:
RECRUITING
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Cholangiocarcinoma
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The main objective is to describe the evolution of patients treated for a primary malignant hepatobiliary tumor (hepatocellular carcinoma or cholangiocarcinoma) over the long course.
Detailed Description
The collection of data from patients with CHC and cholangiocarcinomas who are cancers with poor prognosis is a major challenge to improve patients'care (diagnosis, prognosis); facilitate the search fo...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- Age ≥ 18 years olds
- Medical care in Nephrology department since 2015
- Cholangiocarcinoma:
- \- Histologically and cytologically documented cholangiocarcinoma, regardless of the stage of the disease
- Hepatocellular carcinoma:
- Hepatocellular carcinoma at any stage of the disease, presenting the diagnostic criteria according to the diagnostic criteria of Barcelona : Tumor of more than 1 cm, developed on cirrhosis liver with arterial phase hyperenhancement and washout in the portal venous or delayed phases on CT and MRI
- Hepatocellular histologically documented
Exclusion
- \- Lack of patient non-opposition
Key Trial Info
Start Date :
September 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2030
Estimated Enrollment :
1250 Patients enrolled
Trial Details
Trial ID
NCT04340986
Start Date
September 2 2020
End Date
September 1 2030
Last Update
June 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Serviec hépatologie-Hôpital Saint Antoine
Paris, France, 75012